The HER2 diagnostic and treatment landscape in NSCLC

Episode 2: Navigating common treatment scenarios in HER2-mutant NSCLC

This is the second episode of a two-part series on the HER2 diagnostic and treatment landscape in NSCLC, hosted by the Oncology Brothers, Drs Rohit and Rahul Gosain.

In this episode Drs Isabel Preeshagul and Eric Singhi provide the benefit of their experience when discussing how to approach different treatment scenarios in HER2-mutant NSCLC.

The conversation unfolds to cover;

How to distinguish HER2 alterations from other alterations on biomarker reports

The latest efficacy and safety data of currently approved and emerging treatments for HER2-altered NSCLC

The potential CNS activity of these treatments in patients with HER2-mutated NSCLC

How the treatment pathway may look in the near future

This is the full video. Watch the shorter highlights video here:    • Highlights: The HER2 diagnostic and treatm...  

Listen to the audio version of this conversation on Spotify, Apple, or on the COR2ED website, where you can also download the accompanying transcript: https://cor2ed.com/lung-connect/progr...



Follow LUNG CONNECT on social media:

X – https://x.com/lung_connect

LinkedIn –   / lungconnect  

This content is intended for healthcare professionals only. The medical experts in this video are expressing their own views and not those of COR2ED, Supporters or their institution. This video is supported by an Independent Education Grant from Bayer.



This video is developed by cor2ed.com

Published on April 2025



Subscribe to this channel to stay up to date with new Independent Education programmes as they’re released.